• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	115,600	18.07.24 09:04:29	+0,600	+0,52%	115,200	116,200	115,600	115,000
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	92,500	18.07.24 08:37:40	+2,000	+2,21%	92,500	93,500	92,500	90,500